Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib plus cisplatin chemoradiotherapy in locally advanced head and neck squamous cell carcinoma
2005-003767-23Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in head and neck squamous cell carcinoma (HNSCC) comparing Lapatinib + cisplatin + radiotherapy with Placebo + cisplatin + radiotherapy (2 arms). Primary endpoint: Complete response rate. Started Apr 2006; status: completed.
02
Drugs
lapatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2005-003767-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003767-23.